NCT02867371CompletedNot Applicable
Evaluation of the Archimedes™ System for Transparenchymal Nodule Access 2
Conditions
Interventions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Broncus Medical Inc
- Enrollment
- 166
- Locations
- 16
- Primary Endpoint
- Proportion of biopsies yielding tissue sufficient for diagnosis
Study Overview
Brief Summary
The Archimedes System is an image-guided navigation system used to access tissue samples in the lungs. This study is being conducted to confirm the performance of the Archimedes System in patients who are scheduled for standard bronchoscopy to diagnose highly suspicious lung cancer or metastatic disease. Navigation to and sampling of the patient's lung cancer tumor is conducted.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 21 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age 21-75 years at screening
- •Highly suspicious pulmonary nodule(s), defined as distinct nodule with a diameter of ≥8mm in its largest dimension
- •No known endobronchial tumor
- •Tumor located anywhere in parenchymal tissue >1 cm from pleura and accessible bronchoscopically through a POE.
- •Willing to participate in all aspects of study protocol for duration of study
- •Able to understand study requirements
- •Subject or legally authorized representative signs study-related informed consent document
Exclusion Criteria
- •Any contraindication to bronchoscopy, for example:
- •Untreatable life-threatening arrhythmias
- •Inability to adequately oxygenate the patient during the procedure
- •Acute respiratory failure with hypercapnia (unless the patient is intubated and ventilated)
- •Recent myocardial infarction
- •Previously diagnosed high-grade tracheal obstruction
- •Uncorrectable coagulopathy
- •Known coagulopathy
- •Platelet dysfunction or platelet count < 100 x 103 cells/mm3
- •History of major bleeding with bronchoscopy
- •Suspected pulmonary hypertension: additional testing required, such as echocardiogram
- •Moderate-to-severe pulmonary fibrosis
- •Severe emphysema or COPD: additional testing and PI consent is required
- •Bullae >5 cm located in vicinity of target nodule or tunnel
- •Any other severe or life-threatening comorbidity that could increase the risk of bronchoscopic biopsy or ATV tunneling, for example:
- •ASA class > 3
- •> stage 3 heart failure
- •severe cachexia
- •severe respiratory insufficiency or hypoxia
- •Ongoing systemic infection
- •Contraindication to general anesthesia
- •Inability to stop anticoagulants (e.g., heparin, Warfarin) or antiplatelet agents (e.g. aspirin, clopidogrel) prior to procedure
- •Participation in any other study in last 30 days
- •Prior thoracic surgery on the same side of the lung as the SPN.
- •Breastfeeding women or females of childbearing potential with a positive pregnancy test prior to the procedure or the intent to become pregnant during the study.
- •Life expectancy of less than one year.
- •Scheduled for lung surgery within 72hrs post-scheduled diagnostic bronchoscopy
- •Prior radiation therapy treatment in the target lobe
Arms & Interventions
-Navigation and tissue sampling
Experimental
Guided bronchoscopic navigation and lung tissue sampling using the Archimedes System
Intervention: Archimedes System (Device)
Outcomes
Primary Outcomes
Proportion of biopsies yielding tissue sufficient for diagnosis
Time Frame: Up to 1 year
The number of nodules with at least one biopsy sufficient for a definitive tissue diagnosis divided by the number of nodules sampled by the Archimedes System.
Secondary Outcomes
- Patient registration time(Up to 1 year)
- Procedure planning time(Up to 1 year)
- Fluoroscopy time(Up to 1 year)
- Nodule access time(Up to 1 year)
Investigators
Study Sites (16)
Loading locations...
Similar Trials
Terminated
Not Applicable
Evaluation of the Archimedes™ System for Transparenchymal Nodule AccessLung CancerNCT02460120Broncus Medical Inc9
Completed
Not Applicable
Navigation System for Percutaneous TracheotomyTracheostomy ComplicationVentilation Therapy ComplicationsNCT04744909Karolinska University Hospital48
Unknown
Phase 3
The LightPath® and 68Ga-RM2 in Breast Cancer StudyBreast CancerNCT03731026Lightpoint Medical Limited80
Not yet recruiting
Not Applicable
Evaluation of a new vessel imaging system to support venous cannulation in children.venous cannulation, venipuncture, near-infrared, vessel visualization, VascuLuminator.Veneuze cannulatie, infuus, venapunctie, infrarood licht, vaat imaging, VascuLuminatorNL-OMON27154MC Utrecht200
Completed
Not Applicable
Evaluation of Image-Guided Liver Surgical System for Resection of Liver CancerLiver CancerNCT00782886Pathfinder Therapeutics75